欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
PT/H/0618/001
药品名称
Paracetamol Basi
活性成分
paracetamol 40.0 mg/ml
剂型
Syrup
上市许可持有人
Laboratórios Basi - Industria Farmacêutica, SA Coimbra Portugal
参考成员国 - 产品名称
Portugal (PT)
互认成员国 - 产品名称
Czechia (CZ)
Belgium (BE)
Paracetamol Teva 40 mg/ml suspensie voor oraal gebruik
Luxembourg (LU)
United Kingdom (Northern Ireland) (XI)
Austria (AT)
Paracetamol Basi 40 mg/ml Sirup
Latvia (LV)
APAPKIT 40 mg/ml suspensija iekšķīgai
Estonia (EE)
PARACETAMOL BASI 40 MG/ML
Hungary (HU)
SUPOFEN 40 mg/ml belsőleges szuszpenzió
Bulgaria (BG)
Paracetamol Basi
Romania (RO)
Supofen 40 mg/ml suspensie orala
Slovenia (SI)
Supofen 40 mg/ml peroralna suspenzija
Malta (MT)
Supofen 200mg/5ml oral suspension
许可日期
2012/11/14
最近更新日期
2024/04/08
药物ATC编码
N02BE01 paracetamol
申请类型
TypeLevel1:
Abridged
TypeLevel2:
Initial Application
TypeLevel3:
Generic Art 10.1 and 10.2 Dir 2001/83/EC
TypeLevel4:
Chemical Substance
TypeLevel5:
Prescription Only
附件文件下载
PubAR
|
Paracetamol_Basi_Scientific_discussion_PAR_JUN2015_PHG_resposta_19JUN_2015_IRS_PHG
Date of last change:2024/09/06
PubAR Summary
|
Paracetamol_Basi_Summary PAR_JUN2015_PHG
Date of last change:2024/09/06
市场状态
Positive
©2006-2025
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase